Cargando…
Phenotyping, Etiological Factors, and Biomarkers: Toward Precision Medicine in Autism Spectrum Disorders
Despite the progress made in understanding the biology of autism spectrum disorder (ASD), effective biological interventions for the core symptoms remain elusive. Because of the etiological heterogeneity of ASD, identification of a “one-size-fits-all” treatment approach will likely continue to be ch...
Autor principal: | Beversdorf, David Q. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5102276/ https://www.ncbi.nlm.nih.gov/pubmed/27676697 http://dx.doi.org/10.1097/DBP.0000000000000351 |
Ejemplares similares
-
Editorial: Precision medicine approaches for heterogeneous conditions such as autism spectrum disorders (The need for a biomarker exploration phase in clinical trials - Phase 2m)
por: Beversdorf, David Q., et al.
Publicado: (2023) -
Saliva RNA Biomarkers of Gastrointestinal Dysfunction in Children With Autism and Neurodevelopmental Disorders: Potential Implications for Precision Medicine
por: Beversdorf, David Q., et al.
Publicado: (2022) -
The Broader Autism Phenotype and Its Implications on the Etiology and Treatment of Autism Spectrum Disorders
por: Gerdts, Jennifer, et al.
Publicado: (2011) -
Comorbidities in autism spectrum disorder and their etiologies
por: Khachadourian, Vahe, et al.
Publicado: (2023) -
Editorial: Personalized Precision Medicine in Autism Spectrum-Related Disorders
por: Gabis, Lidia V., et al.
Publicado: (2021)